Lipoprotein News and Research

RSS
A lipoprotein is a biochemical assembly that contains both proteins and lipids. The lipids or their derivatives may be covalently or non-covalently bound to the proteins.
Researchers find molecular mechanism that may be responsible for development of amyloidoses

Researchers find molecular mechanism that may be responsible for development of amyloidoses

Disclosing genetic risk for CHD results in lower low-density lipoprotein cholesterol

Disclosing genetic risk for CHD results in lower low-density lipoprotein cholesterol

Genvoya approved as complete regimen for HIV treatment

Genvoya approved as complete regimen for HIV treatment

HDL not so good in protecting women against atherosclerosis, study shows

HDL not so good in protecting women against atherosclerosis, study shows

Repatha (evolocumab) injection gets FDA approval for high cholesterol

Repatha (evolocumab) injection gets FDA approval for high cholesterol

No lasting metabolic health costs from combined GH and GnRH analogue therapy

No lasting metabolic health costs from combined GH and GnRH analogue therapy

Novel approach to reduce 'bad' lipids in blood circulation

Novel approach to reduce 'bad' lipids in blood circulation

Familial hypercholesterolemia patients can benefit from alirocumab drug

Familial hypercholesterolemia patients can benefit from alirocumab drug

Amgen to present data on Repatha (evolocumab) and observational studies at ESC Congress 2015

Amgen to present data on Repatha (evolocumab) and observational studies at ESC Congress 2015

Novel technique may lead to therapies for pain relief in individuals with intractable pain

Novel technique may lead to therapies for pain relief in individuals with intractable pain

Resverlogix announces formation of international Clinical Steering Committee for RVX-208 "apabetalone" Phase 3 trial

Resverlogix announces formation of international Clinical Steering Committee for RVX-208 "apabetalone" Phase 3 trial

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

EMA's CHMP recommends approval of Praluent (alirocumab) for use in patients with hypercholesterolemia

EMA's CHMP recommends approval of Praluent (alirocumab) for use in patients with hypercholesterolemia

Study examines accuracy, cost-effectiveness of new cholesterol guidelines in identifying increased CVD risk

Study examines accuracy, cost-effectiveness of new cholesterol guidelines in identifying increased CVD risk

Wayne State researchers explore effects of Tocotrienol-rich fraction from palm oil in ESRD patients

Wayne State researchers explore effects of Tocotrienol-rich fraction from palm oil in ESRD patients

Virginia Tech researchers develop new scoring method for assessing overall beverage intake quality

Virginia Tech researchers develop new scoring method for assessing overall beverage intake quality

Phase 3 ODYSSEY JAPAN trial of Praluent injection meets primary endpoint

Phase 3 ODYSSEY JAPAN trial of Praluent injection meets primary endpoint

Darapladib shows promise in diabetic macular oedema

Darapladib shows promise in diabetic macular oedema

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Tree nut consumption associated with lower body weight and lower risk of obesity

Tree nut consumption associated with lower body weight and lower risk of obesity

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.